Scientific publications

PLOS Computational Biology, 2025

Exploration of potential novel drug targets for rheumatoid arthritis by plasma proteome screening

Ma Z., Chen R., Feng Z.

Inflammatory Bowel Diseases, 2025

Genome-Wide Aggregated Trans-Effects Analysis Implicates Deficient Type III Interferon Signaling as a Key Cause of Inflammatory Bowel Disease

McKeigue P., Iakovliev A., Erabadda B. et al.

Cardiovascular Research, 2025

A multi-omics approach uncovers causality of IL6R on endotypes of subclinical carotid atherosclerosis and the possible role of the IL6R/OSMR pathway

Chen Q., Björck H., Bergman O. et al.

Communications Chemistry, 2025

Current landscape of plasma proteomics from technical innovations to biological insights and biomarker discovery

Kirsher D., Chand S., Phong A. et al.

Psychoneuroendocrinology, 2025

Relationships between childhood adversity, resilience, and inflammatory profiles in Taiwanese young adults

Jaimes M., Chaimano S., Lin S. et al.

Cancer Letters, 2025

An anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) and chemotherapy for RAS/BRAF wild-type metastatic colorectal cancer: A phase Ib study

Bai M., Li N., Yin X. et al.

Science Translational Medicine, 2025

Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulation

He Z., Glass M., Venkatesan P. et al.

Thorax, 2025

Proteomics-based risk prediction and drug targets identification for chronic obstructive pulmonary disease

Zhang Y., Ye Z., Yang S. et al.

Nature Communications, 2025

Shared genetic architecture contributes to risk of major cardiovascular diseases

Qiao J., Jiang L., Cai L. et al.

JAMA Dermatology, 2025

Mediterranean Diet and Patients With Psoriasis

Perez-Bootello J., Berna-Rico E., Abbad-Jaime de Aragon C. et al.

Discover Oncology, 2025

Causal effects of circulating inflammatory proteins on colorectal cancer: a Mendelian randomization and Spatial transcriptomic study

Bai M., Wu B., Li J. et al.

Movement Disorders Clinical Practice, 2025

High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's Disease

Sturchio A., Paslawski W., Khosousi S. et al.

International Journal of Molecular Sciences, 2025

Neuroprotective Effects of Vesatolimod in EAE: Modulating Immune Balance and Microglial Polarization

Chen X., Zhang J., Mu S.

Circulation: Heart Failure, 2025

Transpulmonary Proteome Gradients Identify Pathways Involved in Pulmonary Vascular Disease Due To Heart Failure

Melenovsky V., Jarolim P., Kutilkova E. et al.

JHEP Reports, 2025

PD-L1 and the risk of bacterial infection in patients with chronic liver diseases. An international multicohort study.

Juanola A., Mezzano G., Pose E. et al.

iScience, 2025

Identification of IL18/IL18R1 signaling as a predictive biomarker of SGLT2 inhibitor efficacy in type 2 diabetes

Teng I., Lee C., Chen Y. et al.

eBioMedicine, 2025

Plasma neurology-related proteins associated with cognition are modulated by lifestyle in adults

Margara-Escudero H., Paz-Graniel I., García-Gavilán J. et al.

BMJ Open, 2025

Mendelian randomisation and single-cell transcriptomic analyses reveal serotonin promotes multiple sclerosis progression by suppressing adenosine deaminase activity

Huang L., Shi J., Li H. et al.

Medicine, 2025

The causal relationship between 91 inflammatory cytokines and chronic pancreatitis, and the mediating role of 1400 metabolites

Yang C., Wang Y., Liu L. et al.

Medicine, 2025

Genetically proxied glucagon-like peptide-1 receptor agonist is associated with risk of tubulo-interstitial nephritis: A network Mendelian randomization study

Xu X., Huang F., Ying J. et al.